Author: Matthew Nelson|| Date Published: July 30, 2019
Battelle has entered into a contractor agreement with the Defense Advanced Research Projects Agency to develop a platform designed to identify epigenome signatures that could be used to determine an individual™s exposure to materials associated with weapons of mass destruction.
Under DARPA™s Epigenetic Characterization and Observation program, Battelle said Monday it will identify unique signatures by comparing blood samples from individuals that have dealt with chemical, biological, pesticide or herbicide contaminants to those of control subjects.
œWe™ll be developing methods to identify these signatures and how to interpret them for attribution”what did the person handle, when and for how long, said Rachel Spurbeck, a principal research scientist and biologist at Battelle. œThis will even allow for diagnosing illnesses in individuals as a result of their exposure.
The nonprofit company said the proposed technology will trace a specific epigenome from a biological sample despite the absence of other physical evidence.
AeroVironment has tapped Robert “Rob” Smith as executive vice president and chief operating officer. Smith’s appointment, which will become official April 13, underscores…
GreyNoise Intelligence has launched Command and Control Detection, a new intelligence module designed to identify active cyber compromises using outbound…
BigBear.ai has named Jo Ann Bjornson as chief human resources officer and Alex Thompson as chief corporate affairs officer. The new leadership appointments…
